772 related articles for article (PubMed ID: 15989949)
1. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.
Maeda S; Kamata H; Luo JL; Leffert H; Karin M
Cell; 2005 Jul; 121(7):977-90. PubMed ID: 15989949
[TBL] [Abstract][Full Text] [Related]
2. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
Sakurai T; Maeda S; Chang L; Karin M
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
[TBL] [Abstract][Full Text] [Related]
3. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration.
Nozaki Y; Hikita H; Tanaka S; Fukumoto K; Urabe M; Sato K; Myojin Y; Doi A; Murai K; Sakane S; Saito Y; Kodama T; Sakamori R; Tatsumi T; Takehara T
Sci Rep; 2021 Feb; 11(1):3363. PubMed ID: 33564095
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis.
Sakurai T; He G; Matsuzawa A; Yu GY; Maeda S; Hardiman G; Karin M
Cancer Cell; 2008 Aug; 14(2):156-65. PubMed ID: 18691550
[TBL] [Abstract][Full Text] [Related]
5. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
[TBL] [Abstract][Full Text] [Related]
6. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
7. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
[TBL] [Abstract][Full Text] [Related]
9. STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.
Kaltenecker D; Themanns M; Mueller KM; Spirk K; Golob-Schwarzl N; Friedbichler K; Kenner L; Haybaeck J; Moriggl R
Cytokine; 2019 Dec; 124():154573. PubMed ID: 30377054
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of hepatocyte Ikkbeta confers growth advantages.
Koch KS; Maeda S; He G; Karin M; Leffert HL
Biochem Biophys Res Commun; 2009 Mar; 380(2):349-54. PubMed ID: 19171122
[TBL] [Abstract][Full Text] [Related]
11. Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes.
Majumder S; Roy S; Kaffenberger T; Wang B; Costinean S; Frankel W; Bratasz A; Kuppusamy P; Hai T; Ghoshal K; Jacob ST
Cancer Res; 2010 Dec; 70(24):10265-76. PubMed ID: 21159647
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.
Wree A; Johnson CD; Font-Burgada J; Eguchi A; Povero D; Karin M; Feldstein AE
Cell Death Differ; 2015 Dec; 22(12):1985-94. PubMed ID: 25909884
[TBL] [Abstract][Full Text] [Related]
13. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.
Van TM; Polykratis A; Straub BK; Kondylis V; Papadopoulou N; Pasparakis M
J Clin Invest; 2017 Jun; 127(7):2662-2677. PubMed ID: 28628031
[TBL] [Abstract][Full Text] [Related]
14. Overproduction of thrombopoietin by BRAFV600E-mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis.
Tanaka H; Horioka K; Yamamoto M; Asari M; Okuda K; Yamazaki K; Shimizu K; Ogawa K
Cancer Sci; 2019 Sep; 110(9):2748-2759. PubMed ID: 31301081
[TBL] [Abstract][Full Text] [Related]
15. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
16. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.
Chen CC; Kim KH; Lau LF
Oncogene; 2016 Mar; 35(10):1314-23. PubMed ID: 26028023
[TBL] [Abstract][Full Text] [Related]
17. Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
Shirakami Y; Gottesman ME; Blaner WS
Carcinogenesis; 2012 Feb; 33(2):268-74. PubMed ID: 22116467
[TBL] [Abstract][Full Text] [Related]
18. IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha.
Maeda S; Chang L; Li ZW; Luo JL; Leffert H; Karin M
Immunity; 2003 Nov; 19(5):725-37. PubMed ID: 14614859
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology of early stage chemically induced hepatocarcinogenesis.
Ogawa K
Pathol Int; 2009 Sep; 59(9):605-22. PubMed ID: 19712128
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of CD74 in Ikkβ-deleted mouse hepatocytes.
Koch KS; Leffert HL
Acta Histochem; 2011 Jul; 113(4):428-35. PubMed ID: 20569972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]